Literature DB >> 15082611

Assessment of reflux symptom severity: methodological options and their attributes.

P Bytzer1.   

Abstract

Despite major advances in our understanding of reflux disease, the management of this disorder still presents many challenges. Reduction of heartburn is the most readily apparent objective for the patient with reflux disease. Thus the ability to measure heartburn accurately is of fundamental importance to clinical research in reflux disease. Here, the available data on the assessment of reflux symptoms--predominantly heartburn--in clinical trials of symptomatic reflux disease are examined.

Entities:  

Mesh:

Year:  2004        PMID: 15082611      PMCID: PMC1867778          DOI: 10.1136/gut.2003.034298

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  Factors influencing compliance in long-term proton pump inhibitor therapy in general practice.

Authors:  A P Hungin; G Rubin; H O'Flanagan
Journal:  Br J Gen Pract       Date:  1999-06       Impact factor: 5.386

2.  High dose proton pump inhibitor response as an initial strategy for a clinical diagnosis of gastro-oesophageal reflux disease (GERD). Swedish multi-centre group in primary health care.

Authors:  J Brun; H Sörngård
Journal:  Fam Pract       Date:  2000-10       Impact factor: 2.267

3.  Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn.

Authors:  R A Faaij; J M Van Gerven; I Jolivet-Landreau; A A Masclee; E M Vendrig; R C Schoemaker; L D Jacobs; A F Cohen
Journal:  Aliment Pharmacol Ther       Date:  1999-12       Impact factor: 8.171

4.  Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  D A Revicki; J A Crawley; M W Zodet; D S Levine; B O Joelsson
Journal:  Aliment Pharmacol Ther       Date:  1999-12       Impact factor: 8.171

5.  Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.

Authors:  J E Richter; D Peura; S B Benjamin; B Joelsson; J Whipple
Journal:  Arch Intern Med       Date:  2000-06-26

6.  Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.

Authors:  J E Richter; D R Campbell; P J Kahrilas; B Huang; C Fludas
Journal:  Arch Intern Med       Date:  2000-06-26

7.  Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months.

Authors:  N J Talley; K Lauritsen; H Tunturi-Hihnala; T Lind; B Moum; C Bang; T Schulz; T M Omland; M Delle; O Junghard
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

8.  Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

Authors:  D A Johnson; S B Benjamin; N B Vakil; J L Goldstein; M Lamet; J Whipple; D Damico; B Hamelin
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

9.  Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease.

Authors:  R Fass; J J Ofman; I M Gralnek; C Johnson; E Camargo; R E Sampliner; M B Fennerty
Journal:  Arch Intern Med       Date:  1999-10-11

10.  Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

Authors:  J E Richter; P J Kahrilas; J Johanson; P Maton; J R Breiter; C Hwang; V Marino; B Hamelin; J G Levine
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

View more
  11 in total

1.  Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Raffaele Manta; Leonardo Frazzoni; Gianluigi Melotti
Journal:  Surg Endosc       Date:  2013-02-23       Impact factor: 4.584

2.  Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid.

Authors:  Wade Thompson; Barbara Farrell; Vivian Welch; Peter Tugwell; Lise M Bjerre
Journal:  Can Pharm J (Ott)       Date:  2016-11-30

Review 3.  Laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Leonardo Frazzoni; Gianluigi Melotti
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  Age and body mass index: significant predictive factors for successful laparoscopic antireflux surgery.

Authors:  Tomoyuki Irino; Hiroya Takeuchi; Soji Ozawa; Yoshiro Saikawa; Takashi Oyama; Kunihiko Hiraiwa; Takahisa Yoshikawa; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

5.  Study of respiratory disorders in endoscopically negative and positive gastroesophageal reflux disease.

Authors:  Maha M Maher; Amr A Darwish
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

6.  Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition?

Authors:  Enrique Rey; Marta Barceló; Javier Zapardiel; Eduardo Sobreviela; Mercedes Muñoz; Manuel Díaz-Rubio
Journal:  BMC Gastroenterol       Date:  2014-01-22       Impact factor: 3.067

7.  Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.

Authors:  V Savarino; F Pace; C Scarpignato
Journal:  Aliment Pharmacol Ther       Date:  2017-01-24       Impact factor: 8.171

8.  Removing the Mask of Average Treatment Effects in Chronic Lyme Disease Research Using Big Data and Subgroup Analysis.

Authors:  Lorraine Johnson; Mira Shapiro; Jennifer Mankoff
Journal:  Healthcare (Basel)       Date:  2018-10-12

Review 9.  Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study.

Authors:  Gerdine A J Fransen; Corine J van Marrewijk; Suhreta Mujakovic; Jean W M Muris; Robert J F Laheij; Mattijs E Numans; Niek J de Wit; Melvin Samsom; Jan B M J Jansen; J André Knottnerus
Journal:  BMC Med Res Methodol       Date:  2007-04-23       Impact factor: 4.615

10.  Management of gastroesophageal reflux disease: a review of medical and surgical management.

Authors:  Nirali Shah; Sandhya Iyer
Journal:  Minim Invasive Surg       Date:  2014-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.